194 related articles for article (PubMed ID: 21214407)
21. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
[TBL] [Abstract][Full Text] [Related]
22. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
[TBL] [Abstract][Full Text] [Related]
23. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
Popovici C; Zhang B; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Blood; 1999 Feb; 93(4):1381-9. PubMed ID: 9949182
[TBL] [Abstract][Full Text] [Related]
24. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
[TBL] [Abstract][Full Text] [Related]
25. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
[TBL] [Abstract][Full Text] [Related]
26. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
[TBL] [Abstract][Full Text] [Related]
27. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC
Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006
[TBL] [Abstract][Full Text] [Related]
28. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
[TBL] [Abstract][Full Text] [Related]
29. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
30. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.
Sahin F; Sercan Z; Ertan Y; Ocakci S; Ay E; Vural F; Yuksel E; Tombuloglu M; Saydam G
Hematology; 2007 Dec; 12(6):489-92. PubMed ID: 17852454
[TBL] [Abstract][Full Text] [Related]
31. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
[TBL] [Abstract][Full Text] [Related]
32. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
[No Abstract] [Full Text] [Related]
33. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract][Full Text] [Related]
34. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
[TBL] [Abstract][Full Text] [Related]
35. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
36. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
37. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
Walz C; Chase A; Schoch C; Weisser A; Schlegel F; Hochhaus A; Fuchs R; Schmitt-Gräff A; Hehlmann R; Cross NC; Reiter A
Leukemia; 2005 Jun; 19(6):1005-9. PubMed ID: 15800673
[TBL] [Abstract][Full Text] [Related]
38. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
[TBL] [Abstract][Full Text] [Related]
39. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
[TBL] [Abstract][Full Text] [Related]
40. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
